Clinical trial
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
NCT05773144 is registered in ClinicalTrials.gov with AdventHealth Translational Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
- Lead sponsor
- AdventHealth Translational Research Institute
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 1, 2023
- Completion date
- May 1, 2027
- Enrollment
- 219 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.